Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Mark J. Rutherford"'
Publikováno v:
Population Health Metrics, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background Life expectancy is a simple measure of assessing health differences between two or more populations but current life expectancy calculations are not reliable for small populations. A potential solution to this is to borrow strengt
Externí odkaz:
https://doaj.org/article/acf23b62c70b4820ad78b9c7e97f0f71
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract Background When interested in a time-to-event outcome, competing events that prevent the occurrence of the event of interest may be present. In the presence of competing events, various estimands have been suggested for defining the causal e
Externí odkaz:
https://doaj.org/article/0802e5aa161b4a10964362deed94faff
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background A lack of available data and statistical code being published alongside journal articles provides a significant barrier to open scientific discourse, and reproducibility of research. Information governance restrictions inhibit the
Externí odkaz:
https://doaj.org/article/000f1a1f9cde427d9e34f035f6cbb0d5
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Immortal time bias is common in observational studies but is typically described for pharmacoepidemiology studies where there is a delay between cohort entry and treatment initiation. Methods This study used the Clinical Practice
Externí odkaz:
https://doaj.org/article/97aca0d356894c6ea571d6071cf756b6
Autor:
Mark J. Rutherford, Therese M.-L. Andersson, Tor Åge Myklebust, Bjørn Møller, Paul C. Lambert
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Ensuring fair comparisons of cancer survival statistics across population groups requires careful consideration of differential competing mortality due to other causes, and adjusting for imbalances over groups in other prognostic
Externí odkaz:
https://doaj.org/article/c6e68e1605004a82942c98ab20276664
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-20 (2021)
Abstract Background Royston-Parmar flexible parametric survival models (FPMs) can be fitted on either the cause-specific hazards or cumulative incidence scale in the presence of competing risks. An advantage of modelling within this framework for com
Externí odkaz:
https://doaj.org/article/8dd1d954dc8c4ac4a644738dac391904
Publikováno v:
BMC Medical Research Methodology, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background The life expectancy of cancer patients, and the loss in expectation of life as compared to the life expectancy without cancer, is a useful measure of cancer patient survival and complement the more commonly reported 5-year surviva
Externí odkaz:
https://doaj.org/article/e7c3cd8368fe4bad83f116beab78639d
Autor:
Oras A Alabas, Chris P Gale, Marlous Hall, Mark J. Rutherford, Karolina Szummer, Sofia Sederholm Lawesson, Joakim Alfredsson, Bertil Lindahl, Tomas Jernberg
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 12 (2017)
BackgroundThis study assessed sex differences in treatments, all‐cause mortality, relative survival, and excess mortality following acute myocardial infarction. Methods and ResultsA population‐based cohort of all hospitals providing acute myocard
Externí odkaz:
https://doaj.org/article/a93ccea0d75e4825b81f99dcdfbea548
Publikováno v:
British Journal of Cancer. 127:1061-1068
Background Completeness of recording for cancer stage at diagnosis is often historically poor in cancer registries, making it challenging to provide long-term stage-specific survival estimates. Stage-specific survival differences are driven by differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8771f6531b070c4baa2f4e09432b4f96
https://doi.org/10.1038/s41416-022-01866-8
https://doi.org/10.1038/s41416-022-01866-8
Autor:
Therese M.-L. Andersson, Tor Åge Myklebust, Mark J. Rutherford, Bjørn Møller, Melina Arnold, Isabelle Soerjomataram, Freddie Bray, D. Maxwell Parkin, Paul C. Lambert
Publikováno v:
British Journal of Cancer. 126:1224-1228
Background Comparisons of population-based cancer survival between countries are important to benchmark the overall effectiveness of cancer management. The International Cancer Benchmarking Partnership (ICBP) Survmark-2 study aims to compare survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca6852e2413a2bb799cd655adee2c3f2
https://doi.org/10.1038/s41416-022-01701-0
https://doi.org/10.1038/s41416-022-01701-0